ImmunoPrecise Antibodies Statistics
Total Valuation
IPA has a market cap or net worth of $12.40 million. The enterprise value is $21.22 million.
Important Dates
The next estimated earnings date is Thursday, December 12, 2024, before market open.
| Earnings Date | Dec 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IPA has 28.83 million shares outstanding. The number of shares has increased by 4.73% in one year.
| Shares Outstanding | 28.83M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +1.82% |
| Owned by Insiders (%) | 12.06% |
| Owned by Institutions (%) | 5.74% |
| Float | 25.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| Forward PS | 0.56 |
| PB Ratio | 0.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.49.
| Current Ratio | 0.99 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.65 |
Financial Efficiency
Return on equity (ROE) is -64.04% and return on invested capital (ROIC) is -16.23%.
| Return on Equity (ROE) | -64.04% |
| Return on Assets (ROA) | -13.45% |
| Return on Capital (ROIC) | -16.23% |
| Revenue Per Employee | $172,692 |
| Profits Per Employee | -$198,976 |
| Employee Count | 101 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 6.12 |
Taxes
| Income Tax | -1.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks. The beta is 0.27, so IPA's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 35.28 |
| Average Volume (20 Days) | 976,431 |
Short Selling Information
The latest short interest is 146,079, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 146,079 |
| Short Previous Month | 182,224 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 0.58% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, IPA had revenue of $17.44 million and -$20.10 million in losses. Loss per share was -$0.77.
| Revenue | 17.44M |
| Gross Profit | 8.41M |
| Operating Income | -10.59M |
| Pretax Income | -20.89M |
| Net Income | -20.10M |
| EBITDA | -8.33M |
| EBIT | -10.59M |
| Loss Per Share | -$0.77 |
Full Income StatementBalance Sheet
The company has $2.83 million in cash and $11.66 million in debt, giving a net cash position of -$8.82 million or -$0.31 per share.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | 11.66M |
| Net Cash | -8.82M |
| Net Cash Per Share | -$0.31 |
| Equity (Book Value) | 23.78M |
| Book Value Per Share | 0.87 |
| Working Capital | -111,487 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.99 million and capital expenditures -$1.10 million, giving a free cash flow of -$5.06 million.
| Operating Cash Flow | -3.99M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | -5.06M |
| FCF Per Share | -$0.18 |
Full Cash Flow StatementMargins
Gross margin is 48.20%, with operating and profit margins of -60.69% and -115.22%.
| Gross Margin | 48.20% |
| Operating Margin | -60.69% |
| Pretax Margin | -123.05% |
| Profit Margin | -115.22% |
| EBITDA Margin | -47.75% |
| EBIT Margin | -60.69% |
| FCF Margin | -23.12% |
Dividends & Yields
IPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -162.10% |
| FCF Yield | -40.85% |
Analyst Forecast
The average price target for IPA is $6.00, which is 1,295.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 1,295.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 22.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
IPA has an Altman Z-Score of -1.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.63 |
| Piotroski F-Score | 2 |